Montreux Equity Partners

Status

Active

Location

San Francisco, United States

Total investments

83

Average round size

26M

Portfolio companies

42

Rounds per year

2.77

Lead investments

8

Follow on index

0.49

Exits

22

Stages of investment
Private EquityLate Stage Venture
Areas of investment
BiotechnologyInternetHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeutics

Summary

In 1993 was created Montreux Equity Partners, which is appeared as VC. The main department of described VC is located in the San Francisco. The fund was located in North America if to be more exact in United States.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Montreux Equity Partners, startups are often financed by OrbiMed, Frazier Healthcare Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Frazier Healthcare Partners, Skyline Ventures, Sequoia Capital. In the next rounds fund is usually obtained by Domain Associates, OrbiMed, Skyline Ventures.

The fund was created by Daniel Turner. We also calculated 5 valuable employees in our database.

Among the most popular fund investment industries, there are Internet, Computer. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MINDBODY, Tobira Therapeutics, GC Aesthetics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

The high activity for fund was in 2007. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. This Montreux Equity Partners works on 1 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Montreux Equity Partners is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2007.

Show more

Investor highlights

Check size
10M — 20M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
83
Lead investments
8
Exits
22
Rounds per year
2.77
Follow on index
0.49
Investments by industry
  • Health Care (52)
  • Biotechnology (39)
  • Medical Device (29)
  • Medical (28)
  • Therapeutics (13)
  • Show 47 more
Investments by region
  • United States (73)
  • Ireland (4)
  • Canada (3)
  • Germany (2)
Peak activity year
2005
Number of Unicorns
3
Number of Decacorns
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
195M
Group Appearance index
0.94
Avg. company exit year
11
Avg. multiplicator
2.40
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Blend Media 09 Feb 2017 Marketing, Virtual Reality, Video, Advertising Platforms Seed 1M United Kingdom, London, England
Pulmonx 08 Mar 2010 Health Care, Medical Device Late Stage Venture 32M United States, California, Redwood City
Tebra 06 Jul 2022 Health Care, Electronic Health Record (EHR) Early Stage Venture 72M United States, California, Corona Del Mar

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.